Suchergebnisse - "Woodfall, Brian"

PubPharm (22)

1

ANTI-IL6 AGENT FOR TREATING CORONAVIRUS INFECTION

enthalten in: Europäisches Patentamt | 2021

von BOVEN KATIA | CHIEN JASON | OPSOMER MAGDA | +1

2

Lack of Antiviral Activity of Darunavir against SARS-CoV-2

enthalten in: bioRxiv.org | 2020

von De Meyer, S. | Bojkova, D. | Cinatl, J. | +5

3

Lack of antiviral activity of darunavir against SARS-CoV-2

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2020

von De Meyer, S. | Bojkova, D. | Cinatl, J. | +5

4

Pharmacokinetic evaluation of the interaction between etravirine and rifabutin or clarithromycin in HIV-negative, healthy volunteers : results from two Phase 1 studies

enthalten in: The Journal of antimicrobial chemotherapy | 2014

von Kakuda, T. | Woodfall, B. | De Marez, T. | +4

5

Etravirine in the treatment of HIV-1 : a clinical overview for healthcare professionals

enthalten in: Current HIV research | 2010

von Yeni, P. | Mills, A. | Peeters, M. | +4

6

Impact of the background regimen on virologic response to etravirine : pooled 48-week analysis of DUET-1 and -2

enthalten in: HIV clinical trials | 2010

von Trottier, B. | Di Perri, G. | Madruga, J. | +4

7

A review of the safety and tolerability profile of the next-generation NNRTI etravirine

enthalten in: AIDS research and human retroviruses | 2010

von Grinsztejn, B. | Di Perri, G. | Towner, W. | +3

8

Resistance profile of etravirine : combined analysis of baseline genotypic and phenotypic data from the randomized, controlled Phase III clinical studies

enthalten in: AIDS (London, England) | 2010

von Vingerhoets, J. | Tambuyzer, L. | Azijn, H. | +7

9

Effects of hepatic impairment on the steady-state pharmacokinetics of etravirine 200 mg BID : an open-label, multiple-dose, controlled Phase I study in adults

enthalten in: Clinical therapeutics | 2010

von Schöller-Gyüre, M. | Kakuda, T. | De Smedt, G. | +4

10

Etravirine : clinical review of a treatment option for HIV type-1-infected patients with non-nucleoside reverse transcriptase inhibitor resistance

enthalten in: Antiviral therapy | 2010

von Towner, W. | Cassetti, I. | Domingo, P. | +4